We are not alone — trillions of microbes inhabit each of our bodies creating an ecosystem called the microbiome.
How the microbiome affects health and disease — and how it can be harnessed to develop new therapies for conditions ranging from obesity to cancer — will be the work of a collaboration between the University of Pittsburgh Schools of the Health Sciences and UPMC.
The joint venture, to be called Pitt’s Center for Medicine and the Microbiome, is part of the National Microbiome Initiative that will be announced today at the White House by its Office of Science and Technology policy.
Pitt’s center will be led by Alison Morris, who holds the UPMC Chair for Translational Pulmonary and Critical Care Medicine in Pitt’s School of Medicine. Dr. Morris, who will be attending the White House event today, said she is “very excited” about the potential for major medical breakthroughs by the initiative’s research and clinical partners.
“Both the national initiative and the center here really have a lot of potential to discover new and exciting things about how we get and stay healthy and how we get diseases and how we can develop new therapies for treating them,” she said.
She said the National Microbiome Initiative traces its roots to a National Institutes of Health study seven years ago that classified the variety of microscopic organisms — some good, some bad —that are found in the body.
Read More
“I think this is a rapidly growing area of science and health research and has the potential to be really revolutionary,” Dr. Morris said.
“What’s really exciting is not only understanding what role the microbiome plays in disease but how to use them to prevent disease and to invent new ways to treat various diseases. Technology has developed to the point we can do these studies now.”
As an example, she noted that one’s weight is determined by diet, genetics and the microbes in your gut. “If we can modulate that, we can prevent or treat obesity.”
Arthur S. Levine, Pitt’s senior vice chancellor for the health sciences and the John and Gertrude Petersen Dean of Medicine, said in a statement that the initiative “will enable studies that could explore the impact of the microbiome on cancer, lung conditions, hypertension, heart disease, malnutrition and myriad other conditions.”
Research already underway at UPMC that is expected to be an important contributor to Pitt’s new center is the existing fecal transplantation program which uses “good” microbes to treat various diseases such as Clostridium difficile colitis — a bacterial infection that causes inflammation of the colon — commonly known as C.diff.
Dr. Morris said the results of the national initiative could see practical results in medicine within five years.
“We’re trying to accelerate the research by bringing people together,” she said, ”and it’s not just advances in medicine but in the environment and agriculture and a lot of different disciplines.”
In the near future, the center hopes to launch the Pittsburgh Biome Project, the first of its kind to engage a local community in large-scale microbiome research related not only to current health and disease but also to future disease risk. The project would crowd-source a large collection of gut microbiome samples from local community members.
Michael A. Fuoco: mfuoco@post-gazette.com or 412-263-1968.




Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.